Mauricio Kunz, MD, MSc

  • 2Articles
  • 7.3KReads
  • 2009–2010Active
  • 15Collaborators
  • 232Citations

About

Mauricio Kunz, MD, MSc, has published research on schizophrenia and schizoaffective disorders, focusing on adjunctive therapies for treatment-refractory cases. His work includes clinical trials investigating the effects of memantine as an add-on to clozapine, examining both symptom improvement and biomarkers such as serum brain-derived neurotrophic factor levels. Kunz's publications appeared between 2009 and 2010 in Psychiatrist.com.

Publications

JCP
Letter to the Editor

Lack of Association Between Serum Brain-Derived Neurotrophic Factor Levels and Improvement of Schizophrenia Symptoms in a Double-Blind, Randomized, Placebo-Controlled Trial of Memantine as Adjunctive Therapy to Clozapine

January 15, 2010

, , , et al
JCP
Original Research

Improvement of Negative and Positive Symptoms in Treatment-Refractory Schizophrenia: A Double-Blind, Randomized, Placebo-Controlled Trial With Memantine as Add-On Therapy to Clozapine

October 15, 2009

, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe